Literature DB >> 25648180

CALR mutations screening should not be studied in splanchnic vein thrombosis.

Nerea Castro1, Inmaculada Rapado1, Rosa Ayala1, Joaquin Martinez-Lopez2.   

Abstract

Entities:  

Keywords:  CALR mutations; myeloproliferative neoplasms; splanchnic vein thrombosis

Mesh：

Substances：

Year:  2015        PMID： 25648180     DOI： 10.1111/bjh.13314

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

Review 1.  Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease.

Authors:  Joan How; Amy Zhou; Stephen T Oh
Journal:  Ther Adv Hematol       Date:  2016-12-08

2.  Esophageal location of mantle cell lymphoma.

Authors:  Spyros Michopoulos
Journal:  Ann Gastroenterol       Date:  2016-09-06

3.  CALR mutation analysis is not indicated in patients with splanchnic vein thrombosis without evidence of a myeloproliferative neoplasm: a micro-review.

Authors:  Stephen E Langabeer
Journal:  Ann Gastroenterol       Date:  2016-06-10

4.  Detecting CALR Mutations in Splanchnic Vein Thrombosis: Who and How?

Authors:  Stephen E Langabeer
Journal:  J Transl Int Med       Date:  2018-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.